Two recent studies demonstrated the potential of immunotherapy in NB by improving current anti-GD2 to reduce pain and by creating novel chimeric antigen receptors(CARs) on T cells toward a peptide sequence derived from the master transcriptional regulator in NB PHOX2B.23 The gene discussed is PHOX2B; the disease is neuroblastoma.